Murrayanine suppresses the proliferation and metastasis of human breast cancer cells via induction of apoptosis and inhibition of RANK/RANKL signaling pathway

被引：0
作者：
Jingnan zhang
Feng Wang
Gengbao Qu
Baokai Wang
机构：
[1] Linyi City Central Hospital,Department of Pharmacy
[2] Beijing Tiantan Hospital,Department of Breast Surgery, Fengtai District
[3] Capital Medical University,undefined
来源：
Applied Biological Chemistry | 2021年 / 64卷
关键词：
Breast cancer; Murrayanine; RANK/RANKL pathway; Apoptosis; Metastasis; Anticancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Murrayanine and its derivatives have been shown to exhibit anticancer activities against different types of human cancer cells. However, the effects of murrayanine on the proliferation and metastasis of breast cancer cells are yet to be studied. The present study was designed to evaluate the effects of murrayanine on the proliferation and metastasis of human breast cancer via regulation of RANK/RANKL pathway. The results showed RANK/RANKL pathway to be highly activated in human breast cancer tissues and cell lines. However, treatment of the CAMA-1 breast cancer cells with murrayanine (0, 9, 18 and 36 μM) caused a significant (P < 0.05) decline in the expression of RANK, RANKL and OPG in CAMA-1 cells. Additionally, murrayanine inhibited the growth of CAMA-1 cells with an IC50 of 18 μM. The antiproliferative of murrayanine were found be due to its ability to inhibit the expression of RANK, RANKL and OPG in CAMA-1 cells. To unveil if murrayanine exerted its effects via inhibition of RANK/RANKL pathway, the expression of RNAK was knocked down in CAMA-1 cells. It was found that murrayanine and RANK silencing both inhibited the growth CAMA-1 cells via induction of apoptosis. Additionally, murrayanine and RANK silencing both inhibited the migration, invasion and epithelial to mesenchymal transition of the CAMA-1 cells. Taken together, murrayanine exhibits significant anticancer activity against the breast cancer cells via induction of apoptosis and inhibition of RANK/RANKL signaling pathway. These findings suggest that murrayanine may prove to be a beneficial lead molecule for the development of breast cancer chemotherapy.
引用
收藏
相关论文
共 123 条
[1]  
DeSantis CE(2017)Breast cancer statistics, 2017, racial disparity in mortality by state Cancer J Clin. 67 439-448
[2]  
Ma J(2014)Breast cancer: major risk factors and recent developments in treatment Asian Pac J Cancer Prev 15 3353-3358
[3]  
Goding SA(2017)Risk factors and preventions of breast cancer Int J Biol Sci 13 1387-643
[4]  
Newman LA(2016)Carbazole derivatives: a promising scenario for breast cancer treatment Mini Rev Med Chem 16 630-1756
[5]  
Jemal A(2018)Isolation of carbazole alkaloids and coumarins from Aegle marmelos and Murraya koenigii and their antioxidant properties Sains Malaysiana 47 1749-888
[6]  
Majeed W(2017)Anticancer carbazole alkaloids and coumarins from Clausena plants: a review Chin J Nat Med 15 881-2428
[7]  
Aslam B(2019)Murrayanine exerts antiproliferative effects on human oral cancer cells through inhibition of AKT/mTOR and Raf/MEK/ERK signalling pathways In vitro and inhibits tumor growth in vivo J BUON Off J Balk Union Oncol. 24 2423-144
[8]  
Javed I(2017)Substituted thiazole linked murrayanine-Schiff’s base derivatives as potential anti-breast cancer candidates: Future EGFR Kinase inhibitors Int J Pharm Sci Drug Res 9 139-6
[9]  
Khaliq T(2018)Tert-butyl group bearing murrayanine-chalcone produced noteworthy anti-proliferative activity against breast cancer cell line J Adv Res Biochem Pharmacol 1 4-7
[10]  
Muhammad F(2019)Murrayanine induces cell cycle arrest, oxidative stress, and inhibition of phosphorylated p38 expression in A549 lung adenocarcinoma cells Med Sci Monitor 25 2002-884
12345678910